161 related articles for article (PubMed ID: 24947143)
1. Novel prognostic markers revealed by a proteomic approach separating benign from malignant insulinomas.
Alkatout I; Friemel J; Sitek B; Anlauf M; Eisenach PA; Stühler K; Scarpa A; Perren A; Meyer HE; Knoefel WT; Klöppel G; Sipos B
Mod Pathol; 2015 Jan; 28(1):69-79. PubMed ID: 24947143
[TBL] [Abstract][Full Text] [Related]
2. Increased EpCAM expression in malignant insulinoma: potential clinical implications.
Raffel A; Eisenberger CF; Cupisti K; Schott M; Baldus SE; Hoffmann I; Aydin F; Knoefel WT; Stoecklein NH
Eur J Endocrinol; 2010 Feb; 162(2):391-8. PubMed ID: 20097833
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of the five somatostatin receptor subtypes in human benign and malignant insulinomas - predominance of receptor subtype 4.
Portela-Gomes GM; Stridsberg M; Grimelius L; Rorstad O; Janson ET
Endocr Pathol; 2007; 18(2):79-85. PubMed ID: 17916997
[TBL] [Abstract][Full Text] [Related]
4. Alternative Lengthening of Telomeres and Differential Expression of Endocrine Transcription Factors Distinguish Metastatic and Non-metastatic Insulinomas.
Hackeng WM; Schelhaas W; Morsink FHM; Heidsma CM; van Eeden S; Valk GD; Vriens MR; Heaphy CM; Nieveen van Dijkum EJM; Offerhaus GJA; Dreijerink KMA; Brosens LAA
Endocr Pathol; 2020 Jun; 31(2):108-118. PubMed ID: 32103422
[TBL] [Abstract][Full Text] [Related]
5. Application of laser capture microdissection combined with two-dimensional electrophoresis for the discovery of differentially regulated proteins in pancreatic ductal adenocarcinoma.
Shekouh AR; Thompson CC; Prime W; Campbell F; Hamlett J; Herrington CS; Lemoine NR; Crnogorac-Jurcevic T; Buechler MW; Friess H; Neoptolemos JP; Pennington SR; Costello E
Proteomics; 2003 Oct; 3(10):1988-2001. PubMed ID: 14625861
[TBL] [Abstract][Full Text] [Related]
6. Quantitative proteomics identifies brain acid soluble protein 1 (BASP1) as a prognostic biomarker candidate in pancreatic cancer tissue.
Zhou Q; Andersson R; Hu D; Bauden M; Kristl T; Sasor A; Pawłowski K; Pla I; Hilmersson KS; Zhou M; Lu F; Marko-Varga G; Ansari D
EBioMedicine; 2019 May; 43():282-294. PubMed ID: 30982764
[TBL] [Abstract][Full Text] [Related]
7. Comparison of benign and malignant insulinoma.
Sada A; Yamashita TS; Glasgow AE; Habermann EB; Thompson GB; Lyden ML; Dy BM; Halfdanarson TR; Vella A; McKenzie TJ
Am J Surg; 2021 Feb; 221(2):437-447. PubMed ID: 32873371
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the pancreatic tumor progression by a quantitative proteomic approach and immunhistochemical validation.
Sitek B; Sipos B; Alkatout I; Poschmann G; Stephan C; Schulenborg T; Marcus K; Lüttges J; Dittert DD; Baretton G; Schmiegel W; Hahn SA; Klöppel G; Meyer HE; Stühler K
J Proteome Res; 2009 Apr; 8(4):1647-56. PubMed ID: 19714807
[TBL] [Abstract][Full Text] [Related]
9. Prognostic relevance of UCH-L1 and α-internexin in pancreatic neuroendocrine tumors.
Song YL; Yu R; Qiao XW; Bai CM; Lu CM; Xiao Y; Zhong DR; Chen J; Zhao YP; Zhang TP; Song TT; Gao HL; Wan YH; Shen L; Chen J; Lv B; Hao JJ; Zhang Y; Tang L; Chen YJ
Sci Rep; 2017 May; 7(1):2205. PubMed ID: 28526880
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of cell-cycle regulators in human beta-cells derived from insulinoma tissue.
Ueberberg S; Tannapfel A; Schenker P; Viebahn R; Uhl W; Schneider S; Meier JJ
Metabolism; 2016 May; 65(5):736-746. PubMed ID: 27085780
[TBL] [Abstract][Full Text] [Related]
11. Low expression of aldehyde dehydrogenase 1A1 (ALDH1A1) is a prognostic marker for poor survival in pancreatic cancer.
Kahlert C; Bergmann F; Beck J; Welsch T; Mogler C; Herpel E; Dutta S; Niemietz T; Koch M; Weitz J
BMC Cancer; 2011 Jun; 11():275. PubMed ID: 21708005
[TBL] [Abstract][Full Text] [Related]
12. WHO 2004 criteria and CK19 are reliable prognostic markers in pancreatic endocrine tumors.
Schmitt AM; Anlauf M; Rousson V; Schmid S; Kofler A; Riniker F; Bauersfeld J; Barghorn A; Probst-Hensch NM; Moch H; Heitz PU; Kloeppel G; Komminoth P; Perren A
Am J Surg Pathol; 2007 Nov; 31(11):1677-82. PubMed ID: 18059224
[TBL] [Abstract][Full Text] [Related]
13. Application of fluorescence difference gel electrophoresis saturation labelling for the analysis of microdissected precursor lesions of pancreatic ductal adenocarcinoma.
Sitek B; Lüttges J; Marcus K; Klöppel G; Schmiegel W; Meyer HE; Hahn SA; Stühler K
Proteomics; 2005 Jul; 5(10):2665-79. PubMed ID: 15924292
[TBL] [Abstract][Full Text] [Related]
14. Novel prognostic protein markers of resectable pancreatic cancer identified by coupled shotgun and targeted proteomics using formalin-fixed paraffin-embedded tissues.
Takadate T; Onogawa T; Fukuda T; Motoi F; Suzuki T; Fujii K; Kihara M; Mikami S; Bando Y; Maeda S; Ishida K; Minowa T; Hanagata N; Ohtsuka H; Katayose Y; Egawa S; Nishimura T; Unno M
Int J Cancer; 2013 Mar; 132(6):1368-82. PubMed ID: 22915188
[TBL] [Abstract][Full Text] [Related]
15. Topographic abnormalities of proinsulin to insulin conversion in functioning human insulinomas. Comparison of immunoelectron microscopic and clinical data.
Roth J; Komminoth P; Heitz PU
Am J Pathol; 1995 Aug; 147(2):489-502. PubMed ID: 7639339
[TBL] [Abstract][Full Text] [Related]
16. Serpin peptidase inhibitor clade A member 1 as a potential marker for malignancy in insulinomas.
de Sá SV; Corrêa-Giannella ML; Machado MC; Krogh K; de Almeida MQ; Albergaria Pereira MA; Coelho Siqueira SA; Patzina RA; Ibuki FS; Sogayar MC; Machado MC; Giannella-Neto D
Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5322-30. PubMed ID: 17855650
[TBL] [Abstract][Full Text] [Related]
17. PGP 9.5 immunocytochemical staining for pancreatic endocrine tumors.
Tomita T
Islets; 2013; 5(3):122-8. PubMed ID: 23959334
[TBL] [Abstract][Full Text] [Related]
18. DNA copy number status is a powerful predictor of poor survival in endocrine pancreatic tumor patients.
Jonkers YM; Claessen SM; Perren A; Schmitt AM; Hofland LJ; de Herder W; de Krijger RR; Verhofstad AA; Hermus AR; Kummer JA; Skogseid B; Volante M; Voogd AC; Ramaekers FC; Speel EJ
Endocr Relat Cancer; 2007 Sep; 14(3):769-79. PubMed ID: 17914106
[TBL] [Abstract][Full Text] [Related]
19. Paraneoplastic Ma Antigen-Like 1 as a Potential Prognostic Biomarker in Human Pancreatic Ductal Adenocarcinoma.
Kuwae Y; Kakehashi A; Wakasa K; Wei M; Yamano S; Ishii N; Ohsawa M; Wanibuchi H
Pancreas; 2015 Jan; 44(1):106-15. PubMed ID: 25251443
[TBL] [Abstract][Full Text] [Related]
20. Breast cancer resistance protein expression is associated with early recurrence and decreased survival in resectable pancreatic cancer patients.
Lee SH; Kim H; Hwang JH; Lee HS; Cho JY; Yoon YS; Han HS
Pathol Int; 2012 Mar; 62(3):167-75. PubMed ID: 22360504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
